Provided by Tiger Fintech (Singapore) Pte. Ltd.

BridgeBio Pharma, Inc.

39.78
+0.13000.33%
Post-market: 39.780.00000.00%19:45 EDT
Volume:2.64M
Turnover:104.39M
Market Cap:7.55B
PE:-11.25
High:39.82
Open:38.96
Low:38.57
Close:39.65
Loading ...
Jun 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 30, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 29, 2025

Major Issues Report

Form 8-K - Current report
Apr 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 17, 2025

Major Issues Report

Form 8-K - Current report
Mar 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 28, 2025

Major Issues Report

Form 8-K - Current report
Feb 25, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 25, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 20, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 20, 2025

Major Issues Report

Form 8-K - Current report
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 31, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities